Technology | March 12, 2012

Siemens Expands Acuson S Ultrasound for Easier Access to New Innovations

March 12, 2012 — Siemens Healthcare announced shipment of the Acuson S1000 ultrasound system, a premium ultrasound platform. The Acuson S1000 system expands access to imaging performance at a very low cost of ownership. This system encompasses state-of-the-art ultrasound technology, stellar imaging performance, and versatile applications to provide better patient care. Featuring a complete suite of transducers and capable of performing 27 different exam types, the Acuson S1000 system accommodates a wide spectrum of patients and body types. The Acuson S1000 system is one of the product solutions of Siemens Healthcare’s Agenda 2013 investment program.

Sharing the advanced system design of the industry-leading Acuson S2000 ultrasound system, the Acuson S1000 system produces a high-fidelity ultrasound signal while seamlessly running multiple real-time applications, improving diagnostic confidence in both routine and complex diagnosis. The system also supports a full range of advanced and proven Siemens ultrasound technologies and features, including strain imaging capabilities with eSie Touch elasticity imaging, contrast-enhanced ultrasound with Cadence contrast pulse sequencing technology, and intracardiac echocardiography (ICE) using the Acuson AcuNav ultrasound catheter. Workflow-enhancing applications such as eSieScan workflow protocols and syngo Auto OB measurements are also supported. The new Acuson S1000 ultrasound system features a robust set of applications ranging from radiology and general imaging, including shared service, to obstetrics, gynecology (OB/GYN), and pediatric imaging.

“Our customers and partners demand easy accessibility to state-of-the-art ultrasound technology, premium image performance and versatile applications at a price point that meets their clinical and budgetary needs,” said Jeffrey Bundy, CEO Siemens Healthcare ultrasound business unit. “The Acuson S1000 system delivers on that customer requirement and will continue to do so for years to come.”

Many of the most powerful, clinically proven innovations and applications migrated from the Acuson S Family have been integrated into the Acuson S1000 ultrasound system. Strain imaging capabilities with eSie Touch elasticity imaging assess relative tissue stiffness, enhance mass detection and visualize disease progression for a more informed diagnosis. Supporting a variety of transducers, clinicians can use this technology on a wider range of exam types. Workflow-enhancing tools such as the eSie Scan workflow protocols improve exam consistency as well as knowledge-based applications to automate fetal measurements (syngo Auto OB measurements) and to trace measurements with area, circumference, linear and volume results (syngo eSieCalcs native tracing software). Contrast-enhanced ultrasound with Cadence contrast pulse sequencing technology1 enhances lesion detection with highly sensitive and specific contrast agent signals. And intracardiac echocardiography with the Acuson AcuNav ultrasound catheter enables physicians to perform a complete ultrasound examination during interventional procedures and before the patient leaves the catheterization or electrophysiology lab.

The Acuson S1000 ultrasound system offers multiple configuration options to support a facility’s clinical needs and budget requirements. It supports a comprehensive suite of transducers and exam types to accommodate a wide range of body types, including difficult-to-image bariatric patients. Users can move easily between the Acuson S Family systems, since no learning curve exists and Siemens transducers are compatible with all Acuson S Family solutions. An upgrade path to Siemens’ ultra-premium technologies is currently available exclusively within the Acuson S Family of products.

For more information: www.siemens.com/healthcare

Related Content

This is an example of 3-D ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

This is an example of TriVu ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

Feature | Breast Imaging | September 15, 2021 | By Jennifer Meade
The...
Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated AI decision support tool for cardiac ultrasound.
News | Cardiovascular Ultrasound | September 14, 2021
September 14, 2021 – Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S.
Webinar | Cardiovascular Ultrasound | August 27, 2021
Artificial intelligence is becoming best practice to support clinical decisions and help standardize echocardiography
Webinar | Cardiovascular Ultrasound | August 27, 2021
This educational webinar is focused on the value echocardiographic strain imaging brings to a contemporary cardiology
While doctors have used low-intensity ultrasound as a medical imaging tool since the 1950s, experts at the University of Waterloo are using and extending models that help capture how high-intensity focused ultrasound (HIFU) can work on a cellular level.

The InSightec ExAblate focused ultrasound system developed to treat essential tremor. 

News | Focused Ultrasound Therapy | August 24, 2021
August 24, 2021 — Researchers are bringing the use of acoustic waves to target and destroy cancerous tumors closer to
Images, or a digital twin mitral valve of a patient, created from cardiac ultrasound that were used to perform a virtual surgical procedure to test how the intervention would impact the patient prior to actually performing the procedure. The right image shows color coding for sheer stresses on the valve leaflets before and after the virtual surgery. The left image shows the model quantitation of leaflet coaptation at peak systole prior to the the virtual surgery.

Images, or a digital twin mitral valve of a patient, created from cardiac ultrasound that were used to perform a virtual surgical procedure to test how the intervention would impact the patient prior to actually performing the procedure. The right image shows color coding for sheer stresses on the valve leaflets before and after the virtual surgery. The left image shows the model quantitation of leaflet coaptation at peak systole prior to the the virtual surgery. Read the original article in Plos One.

Feature | Ultrasound Imaging | July 28, 2021
Outside of medicine, computer-generated virtual twins of real machines like cars or airplanes have been used in engin
According to ARRS’ American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) substantially reduces the recall rate, while being unlikely to result in adverse outcome

Normal right mediolateral oblique (A) and craniocarudal (B) view screening mammograms demonstrate density C breasts. Coronal (C), transverse (D), and reconstructed lateral (E) views from supplemental automatic breast ultrasound (ABUS) demonstrates 7 mm circumscribed slightly hypoechoic circumscribed lesion at 11 o’clock position in right breast. Lesion was classified as BI-RADS 3. Patient has undergone yearly mammograms for 4 years following the ABUS examination with no breast cancer diagnosis.

News | Breast Imaging | July 16, 2021
July 16, 2021 —...
ujifilm's robust medical systems portfolio includes a comprehensive product lineup covering CT, MRI, fluoroscopy, digital radiography, women’s health, ultrasound, systems integration, endoscopy and endosurgery, enterprise imaging, assisted reproductive technology, cell culture media, cell therapy development, In-Vitro diagnostics (IVD), and investigational drug development
News | Radiology Imaging | July 14, 2021
July 14, 2021 — Fujifilm announced the launch of the ...
In a mouse model study of MRI-guided focused ultrasound-induced blood-brain barrier (BBB) opening at MRI field strengths ranging from ­approximately 0 T (outside the magnetic field) to 4.7 T, the static magnetic field dampened the detected microbubble cavitation signal and decreased the BBB opening volum

In a mouse model study of MRI-guided focused ultrasound-induced blood-brain barrier (BBB) opening at MRI field strengths ranging from ­approximately 0 T (outside the magnetic field) to 4.7 T, the static magnetic field dampened the detected microbubble cavitation signal and decreased the BBB opening volume. Image courtesy of Washington University in St. Louis

News | Magnetic Resonance Imaging (MRI) | July 13, 2021
July 13, 2021 — ...